cognitive cybersecurity intelligence

News and Analysis


Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer

MALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today…

Source: www.marketscreener.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts